Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Decision: I will not wait for more data. I will act immediately to validate, disclose, and mitigate. The signal is serious, the drug is widely used, and the current label is inadequate. Waiting creates unacceptable patient risk, legal exposure, regulatory damage, and securities-law liability.Read the full answer
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer